Why the study?
Does salicylic acid inhibit arachidonic acid-induced platelet aggregation and thromboxane A2 generation in rats?
Does salicylic acid inhibit arachidonic acid-induced platelet aggregation and thromboxane A2 generation in rats?
Salicylic acid does not inhibit cyclo-oxygenase-mediated platelet aggregation in vivo, suggesting its anti-inflammatory activity is independent of prostaglandin biosynthesis inhibition.
Answers are grounded in this paper and cite their sources.
Salicylic acid antagonizes aspirin's antiplatelet effects in rats; leaves open relevance to human therapy or inflammation pathways.
Arachidonic acid-induced aggregation of rat platelets and the accompanying generation of thromboxane A2 activity were inhibited by aspirin, whereas 20 times higher doses of salicylic, gentisic and salicyluric acids were inactive. Salicylic acid administered to the rats before aspirin prevented the inhibition of the cyclo-oxygenase-mediated effects of arachidonic acid. These results do not support the hypothesis that the anti-inflammatory activity of salicylic acid is due to inhibition of prostaglandin systhetase (cyclo-oxygenase) by an unknown metabolite and indicate that salicylic acid displays an anti-inflammatory activity independent inhibition of prostaglandin biosynthesis.
No takes yet. Share an insight, caveat, or question.
B. Boris Vargaftig (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: